Live News EQUITY FLASH L impact Nov 05, 2026, 10:25 AM UTC CSPC Begins Phase I/II Trial of SYS6062 in China CSPC has begun a Phase I/II trial of SYS6062 for advanced solid tumors in China. SquawkNews Desk